Latest Headlines
Media Relations
Media Coverage

 

News by RSS:

[What is this?]

 

 

Press Release

Northrop Grumman Chooses Appfluent Technology
Appfluent software provides insight into data usage and query performance

Rockville, MD – January 10, 2006 - Appfluent Technology , Inc. the leader in query performance and data usage software, today announced that Northrop Grumman (NYSE: NOC ) - the leader in defense technology, providing a broad array of technologically advanced, innovative products worldwide – has selected Appfluent Technology to help increase operational efficiency of managing and maintaining their Business Intelligence and Data Warehouse deployments.

Appfluent Query Performance helps companies reduce the time and resources spent on resolving query performance issues by instantly delivering insight into how users interact with data. Appfluent’s unique architecture does not require intrusive agents and does not add any performance overhead, eliminating implementation risks and reducing the total cost of ownership.

”Appfluent’s solutions provide Northrop Grumman’s Enterprise IT organization with easy to deploy, easy to manage solutions that deliver instant data usage and query performance insights enabling IT to optimize performance and reduce data management costs for business intelligence, data warehouse and enterprise applications” said Appfluent CEO Frank Gelbart . “The addition of another major Fortune 500 enterprise to our customer roster is further validation that Appfluent has become the vendor of choice for managing business intelligence and data warehouse applications in the enterprise.”

About Appfluent Technology

Appfluent Technology delivers software that provides data usage and query performance analysis to help IT organizations improve performance of Business Intelligence (BI) and enterprise applications, reduce the number of databases they maintain and quickly deploy new applications. Some of the leading companies in the world rely on Appfluent Technology, including Business Objects, Owens & Minor, Morgan Stanley, Pfizer, Hewitt Associates, Avnet and the State of New Jersey.